SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-010075
Filing Date
2022-03-14
Accepted
2022-03-14 16:06:34
Documents
59
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20211231.htm   iXBRL 10-K 2445055
2 EX-23.1 abio-ex231_7.htm EX-23.1 2413
3 EX-31.1 abio-ex311_6.htm EX-31.1 18812
4 EX-31.2 abio-ex312_8.htm EX-31.2 19006
5 EX-32.1 abio-ex321_9.htm EX-32.1 10225
6 GRAPHIC gp5d3jkc4itx000001.jpg GRAPHIC 1063
  Complete submission text file 0001564590-22-010075.txt   6661393

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20211231.xsd EX-101.SCH 37264
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20211231_cal.xml EX-101.CAL 42592
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20211231_def.xml EX-101.DEF 103873
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20211231_lab.xml EX-101.LAB 366412
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20211231_pre.xml EX-101.PRE 252039
53 EXTRACTED XBRL INSTANCE DOCUMENT abio-10k_20211231_htm.xml XML 859718
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 22736598
SIC: 2835 In Vitro & In Vivo Diagnostic Substances